[1]
|
Freeman, A.M. and Pennings, N. (2021) Insulin Resistance. StatPearls, Treasure Island.
|
[2]
|
Gallagher, E.J. and LeRoith, D. (2020) Hyperinsulinaemia in Cancer. Nature Reviews Cancer, 20, 629-644. https://doi.org/10.1038/s41568-020-0295-5
|
[3]
|
李珊珊, 赵钰岚. 胰岛素抵抗及高胰岛素血症促进胰腺癌发生的研究进展[J]. 预防医学, 2021, 33(11), 1122-1125, 1129. https://doi.org/10.19485/j.cnki.issn2096-5087.2021.11.010
|
[4]
|
Thomas, D.D., Corkey, B.E., Istfan, N.W., et al. (2019) Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. Journal of the Endocrine Society, 3, 1727-1747. https://doi.org/10.1210/js.2019-00065
|
[5]
|
Rose, D.P., Gracheck, P.J. and Vona-Davis, L. (2015) The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer. Cancers, 7, 2147-2168. https://doi.org/10.3390/cancers7040883
|
[6]
|
Newton. C.A. and Raskin, P. (2004) Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences. Archives of Internal Medicine, 164, 1925-1931. https://doi.org/10.1001/archinte.164.17.1925
|
[7]
|
Fujita, N., Aono, S., Karasaki, K., et al. (2018) Changes in Lipid Metabolism and Capillary Density of the Skeletal Muscle Following Low-Intensity Exercise Training in a Rat Model of Obesity with Hyperinsulinemia. PLOS ONE, 13, e0196895. https://doi.org/10.1371/journal.pone.0196895
|
[8]
|
Huang, S., Ma, S., Ning, M., et al. (2019) TGR5 Agonist Ameliorates Insulin Resistance in Skeletal Muscles and Improves Glucose Homeostasis in Diabetic Mice. Metabolism, 99, 45-56. https://doi.org/10.1016/j.metabol.2019.07.003
|
[9]
|
Page, M.M. and Johnson, J.D. (2018) Mild Suppression of Hyperinsulinemia to Treat Obesity and Insulin Resistance. Trends in Endocrinology & Metabolism, 29, 389-399. https://doi.org/10.1016/j.tem.2018.03.018
|
[10]
|
Manco., M., Nolfe., G., Pataky., Z., et al. (2017) Shape of the OGTT Glucose Curve and Risk of Impaired Glucose Metabolism in the EGIR-RISC Cohort. Metabolism: Clinical and Experimental, 70, 42-50. https://doi.org/10.1016/j.metabol.2017.02.007
|
[11]
|
Hall, C., Yu, H. and Choi, E. (2020) Insulin Receptor Endocytosis in the Pathophysiology of Insulin Resistance. Experimental & Molecular Medicine, 52, 911-920. https://doi.org/10.1038/s12276-020-0456-3
|
[12]
|
Pinkney, J.H., Stehouwer, C.D., Coppack, S.W., et al. (1997) Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome. Diabetes, 46, S9-S13. https://doi.org/10.2337/diab.46.2.S9
|
[13]
|
Ashcroft, F.M., Harrison, D.E. and Ashcroft, S.J. (1984) Glucose Induces Closure of Single Potassium Channels in Isolated Rat Pancreatic β-Cells. Nature, 312, 446-448. https://doi.org/10.1038/312446a0
|
[14]
|
翟中和, 王喜忠, 丁明孝. 细胞生物学[M]. 北京: 高等教育出版社, 2011: 170-180.
|
[15]
|
Liu, R., Guan, S., Gao, Z., et al. (2021) Pathological Hyperinsulinemia and Hyperglycemia in the Impaired Glucose Tolerance Stage Mediate Endothelial Dysfunction through MiR-21, PTEN/AKT/ENOS, and MARK/ET-1 Pathways. Frontiers in Endocrinology, 12, Article 644159. https://doi.org/10.3389/fendo.2021.644159
|
[16]
|
Li, Z., Feng, P.P., Zhao, Z.B., et al. (2019) Liraglutide Protects against Inflammatory Stress in Non-Alcoholic Fatty Liver by Modulating Kupffer Cells M2 Polarization via CAMP-PKA-STAT3 Signaling Pathway. Biochemical and Biophysical Research Communications, 510, 20-26. https://doi.org/10.1016/j.bbrc.2018.12.149
|
[17]
|
Akerstrom, T., Goldman, D., Nilsson, F., et al. (2020) Hyperinsulinemia Does Not Cause de Novo Capillary Recruitment in Rat Skeletal Muscle. Microcirculation, 27, e12593. https://doi.org/10.1111/micc.12593
|
[18]
|
Jeon, J.Y., Choi, S.E., Ha, E.S., et al. (2019) GLP1 Improves Palmitate-Induced Insulin Resistance in Human Skeletal Muscle via SIRT1 Activity. International Journal of Molecular Medicine, 44, 1161-1171. https://doi.org/10.3892/ijmm.2019.4272
|
[19]
|
Holman, G.D. (2020) Structure, Function and Regulation of Mammalian Glucose Transporters of the SLC2 Family. Pflügers Archiv—European Journal of Physiology, 472, 1155-1175. https://doi.org/10.1007/s00424-020-02411-3
|
[20]
|
Gao, Z., Song, G.Y., Ren, L.P., et al. (2020) β-Catenin Mediates the Effect of GLP-1 Receptor Agonist on Ameliorating Hepatic Steatosis Induced by High Fructose Diet. European Journal of Histochemistry, 64, 225-233. https://doi.org/10.4081/ejh.2020.3160
|
[21]
|
Li, H., Cao, L., Ren, Y., et al. (2018) GLP-1 Receptor Regulates Cell Growth through Regulating IDE Expression Level in Aβ1-42-Treated PC12 Cells. Bioscience Reports, 38, BSR20171284. https://doi.org/10.1042/BSR20171284
|
[22]
|
Guilherme, A., Henriques, F., Bedard, A.H., et al. (2019) Molecular Pathways Linking Adipose Innervation to Insulin Action in Obesity and Diabetes Mellitus. Nature Reviews Endocrinology, 15, 207-225. https://doi.org/10.1038/s41574-019-0165-y
|
[23]
|
Lee, C.L. and Kuo, H.C. (2017) Pathophysiology of Benign Prostate Enlargement and Lower Urinary Tract Symptoms: Current Concepts. Tzu Chi Medical Journal, 29, 79-83. https://doi.org/10.4103/tcmj.tcmj_20_17
|
[24]
|
Cen, H.H., Botezelli, J.D., Wang, S., et al. (2021) Transcriptomic Analysis of Human and Mouse Muscle during Hyperinsulinemia Demonstrates Insulin Receptor Downregulation as a Mechanism for Insulin Resistance. bioRxiv: 556571.
|
[25]
|
Bär, L., Feger, M., Fajol, A., et al. (2018) Insulin Suppresses the Production of Fibroblast Growth Factor 23 (FGF23). Proceedings of the National Academy of Sciences of the United States of America, 115, 5804-5809. https://doi.org/10.1073/pnas.1800160115
|
[26]
|
Dev, R., Bruera, E. and Dalal, S. (2018) Insulin Resistance and Body Composition in Cancer Patients. Annals of Oncology, 29, II18-II26. https://doi.org/10.1093/annonc/mdx815
|
[27]
|
Honors, M.A. and Kinzig, K.P. (2012) The Role of Insulin Resistance in the Development of Muscle Wasting during Cancer Cachexia. Journal of Cachexia, Sarcopenia and Muscle, 3, 5-11. https://doi.org/10.1007/s13539-011-0051-5
|
[28]
|
Dev, R., Del Fabbro, E. and Dalal, S. (2019) Endocrinopathies and Cancer Cachexia. Current Opinion in Supportive and Palliative Care, 13, 286-291. https://doi.org/10.1097/SPC.0000000000000464
|
[29]
|
Kidd, A.C., Skrzypski, M., Jamal-Hanjani, M., et al. (2019) Cancer Cachexia in Thoracic Malignancy: A Narrative Review. Current Opinion in Supportive and Palliative Care, 13, 316-322. https://doi.org/10.1097/SPC.0000000000000465
|
[30]
|
Wang, X., Yan, C. and Liu, J. (2019) Hyperinsulinemia-Induced KLF5 Mediates Endothelial Angiogenic Dysfunction in Diabetic Endothelial Cells. Journal of Molecular Histology, 50, 239-251. https://doi.org/10.1007/s10735-019-09821-3
|
[31]
|
Janssen, J.A. (2021) Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. International Journal of Molecular Sciences, 22, Article 7797. https://doi.org/10.3390/ijms22157797
|
[32]
|
Kim, N.H., Chang, Y., Lee, S.R., et al. (2020) Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer Mortality in Individuals with and without Diabetes. Official Journal of the American College of Gastroenterology, 115, 1840-1848. https://doi.org/10.14309/ajg.0000000000000956
|
[33]
|
Nasiri, A.R., Rodrigues, M.R., Li, Z., et al. (2019) SGLT2 Inhibition Slows Tumor Growth in Mice by Reversing Hyperinsulinemia. Cancer & Metabolism, 7, Article No. 10. https://doi.org/10.1186/s40170-019-0203-1
|
[34]
|
Wang, Y., Nasiri, A.R., Damsky, W.E., et al. (2018) Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer. Cell Reports, 24, 47-55. https://doi.org/10.1016/j.celrep.2018.06.008
|
[35]
|
Nishimura, Y., Musa, I., Holm, L., et al. (2021) Recent Advances in Measuring and Understanding the Regulation of Exercise-Mediated Protein Degradation in Skeletal Muscle. American Journal of Physiology-Cell Physiology, 321, C276-C287. https://doi.org/10.1152/ajpcell.00115.2021
|
[36]
|
Kullmann, S., Hummel, J., Wagner, R., et al. (2022) Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans with Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial. Diabetes Care, 45, 398-406. https://doi.org/10.2337/dc21-1136
|